journal article·2025-09-09Open access

Types of Bone Substitutes and Their Application in Regenerative Medicine: A Systematic Review

Nikoleta Ivanova, Stoyan Ivanov, Stefan Peev, Tsanka Dikova

Abstract

Background: The growing demand for effective methods of bone tissue regeneration highlights the relevance of studying modern bone substitutes and their applications in regenerative medicine. The aim of this work was to conduct a comprehensive analysis of the biological, mechanical, and clinical characteristics of various types of bone substitutes to determine their potential in regenerative medicine. Methods: The study was performed as a systematic literature review in accordance with PRISMA guidelines, analyzing 68 high-quality scientific sources from 2019 to May 2025, using the PubMed, Scopus, Web of Science, and Google Scholar databases. Results: It was established that autogenous grafts exhibit the highest osteogenic properties due to the presence of growth factors BMP-2, BMP-7, and concentrated growth factors; however, their use is limited by donor site morbidity in 20–30% of patients and the requirement to treat 6% of fractures complicated by non-union. Allogeneic and xenogeneic substitutes provide structural support for large defects but require intensive processing in accordance with European Directives 2004/23/EC and 2006/86/EC to minimize the risk of infection transmission. Synthetic substitutes based on calcium phosphate ceramics with pore sizes ranging from 23 to 210 micrometres demonstrate excellent biocompatibility and controlled degradation, with β-tricalcium phosphate exhibiting optimal characteristics for long-term applications compared to calcium sulphate. Conclusions: The findings of the study highlight the necessity of a personalized approach in selecting bone substitutes, considering the specific requirements of medical specialities, and support the development of hybrid biomaterials to combine structural strength with biological activity.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Periodontal Regeneration and Treatments · Mesenchymal stem cell research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biology, Faculty of Pharmacy, Medical University of Varna, 9002 Varna, Bulgaria

Department of Orthopedics and Traumatology, Faculty of Medicine, Medical University of Varna, 9002 Varna, Bulgaria

Department of Periodontology and Dental Implantology, Faculty of Dental Medicine, Medical University of Varna, 9002 Varna, Bulgaria

Department of Dental Material Science and Prosthetic Dental Medicine, Faculty of Dental Medicine, Medical University of Varna, 9002 Varna, Bulgaria

Funding

the European Union-Next Generation EU

References (96)

Show source-provided references
1. Ferraz, M.P. (2023). Bone grafts in dental medicine: An overview of autografts, allografts, and synthetic materials. Materials, 16.10.3390/ma16114117 ↗
2. Heitzer, M., Modabber, A., Zhang, X., Winnand, P., Zhao, Q., Bläsius, F.M., Buhl, E.M., Wolf, M., Neuss, S., and Hölzle, F. (2023). In vitro comparison of the osteogenic capability of human pulp stem cells on alloplastic, allogeneic, and xenogeneic bone scaffolds. BMC Oral Health, 23.10.1186/s12903-023-02726-4 ↗
3. Biomaterials, substitutes, and tissue engineering in bone repair: Current and future concepts10.1007/s00580-017-2507-2 ↗
4. Dahiya, U., Mishra, S., and Bano, S. (2019). Application of bone substitutes and its future prospective in regenerative medicine. Biomaterial-Supported Tissue Reconstruction or Regeneration, IntechOpen.10.5772/intechopen.85092 ↗
5. Manzini, B., Machado, L., Noritomi, P., and Da Silva, J. (2021). Advances in bone tissue engineering: A fundamental review. J. Biosci., 46.10.1007/s12038-020-00122-6 ↗
6. Miletić, M., Puač, N., Škoro, N., Brković, B., Andrić, M., Prokić, B.B., Danilović, V., Milutinović-Smiljanić, S., Mitrović-Ajtić, O., and Mojsilović, S. (2023). Bone regeneration potential of periodontal ligament stem cells in combination with cold atmospheric plasma-pretreated beta-tricalcium phosphate: An in vivo assessment. Appl. Sci., 14.10.3390/app14010016 ↗
7. Mukhlis, S., Issabekova, A., Kudaibergen, G., Mukhambetova, A., Nurkina, A., Altayeva, N., Ashikbayeva, M., Temirzhan, A., Baidarbekov, M., and Ogay, V. (2024). The role of pericytes in bone tissue regeneration and therapeutic applications. Eurasian J. Appl. Biotechnol., 50.10.11134/btp.3S.2024.38 ↗
8. Histological examination of retrieved ePTFE membranes following regenerative surgery of intrabony defects treated with platelet-rich plasma and bone substitutes
9. Tissue engineering and regenerative medicine therapies for cell senescence in bone and cartilage10.1016/j.compositesb.2019.01.034 ↗
10. The clinical use of bone graft substitutes in orthopedic surgery in Germany—A 10-years survey from 2008 to 2018 of 1,090,167 surgical interventions10.1002/jbm.b.34911 ↗
11. Laubach, M., Hildebrand, F., Suresh, S., Wagels, M., Kobbe, P., Gilbert, F., Kneser, U., Holzapfel, B.M., and Hutmacher, D.W. (2023). The concept of scaffold-guided bone regeneration for the treatment of long bone defects: Current clinical application and future perspective. J. Funct. Biomater., 14.10.3390/jfb14070341 ↗
12. Santoro, A., Voto, A., Fortino, L., Guida, R., Laudisio, C., Cillo, M., and D’Ursi, A.M. (2025). Bone defect treatment in regenerative medicine: Exploring natural and synthetic bone substitutes. Int. J. Mol. Sci., 26.10.3390/ijms26073085 ↗
13. Tournier, P., Guicheux, J., Paré, A., Maltezeanu, A., Blondy, T., Veziers, J., Vignes, C., André, M., Lesoeur, J., and Barbeito, A. (2021). A partially demineralized allogeneic bone graft: In vitro osteogenic potential and preclinical evaluation in two different intramembranous bone healing models. Sci. Rep., 11.10.1038/s41598-021-84039-6 ↗
14. Ethical considerations of using a single minor donor for three bone marrow harvests for three HLA-matched siblings with primary immunodeficiency10.1002/pbc.27602 ↗
15. Criteria, challenges, and opportunities for acellularized allogeneic/xenogeneic bone grafts in bone repairing10.1021/acsbiomaterials.2c00194 ↗
16. Ana, I. (2019). Bone substituting materials in dental implantology. Bone Management in Dental Implantology, Springer.10.1007/978-3-319-78951-4_7 ↗
17. Janjua, O.S., Qureshi, S.M., Shaikh, M.S., Alnazzawi, A., Rodriguez-Lozano, F.J., Pecci-Lloret, M.P., and Zafar, M.S. (2022). Autogenous tooth bone grafts for repair and regeneration of maxillofacial defects: A narrative review. Int. J. Environ. Res. Public Health, 19.10.3390/ijerph19063690 ↗
18. Efficacy of concentrated growth factor with autograft and xenograft in mandible fractures: A randomized clinical trial
19. Comparison of bone formation mediated by bone morphogenetic protein delivered by nanoclay gels with clinical techniques (autograft and InductOs®) in an ovine bone model10.1177/20417314221113746 ↗
20. Jin, Y., Zheng, G., Lee, J., and Han, S. (2021). Comparison of demineralized bone matrix and hydroxyapatite as carriers of Escherichia coli recombinant human BMP-2. Biomater. Res., 25.10.1186/s40824-021-00225-7 ↗
21. The effect of autogenous bone graft mixed with recombinant human vascular endothelial growth factor on bone regeneration10.1097/SCS.0000000000007316 ↗
22. Autogenous tooth bone graft and simvastatin combination effect on bone healing10.1097/SCS.0000000000006707 ↗
23. Lower donor site morbidity with hamstring and quadriceps tendon autograft compared with bone-patellar tendon-bone autograft after anterior cruciate ligament reconstruction: A systematic review and network meta-analysis of randomized controlled trials10.1007/s00167-023-07402-2 ↗
24. Donor site morbidity of calcaneal, distal tibial, and proximal tibial cancellous bone autografts in foot and ankle surgery. A systematic review and meta-analysis of 2296 bone grafts
25. Quantifying donor site morbidity in anterior cruciate ligament reconstruction using peroneus longus tendon autograft
26. Advances in autogenous dentin matrix graft as a promising biomaterial for guided bone regeneration in the maxillofacial region: A review10.1097/MD.0000000000039422 ↗
27. Effects of allogeneic bone substitute configurations on the cell adhesion process in vitro10.1111/os.13395 ↗
28. European Parliament and Council (2004). Directive 2004/23/EC of the European Parliament and of the Council of 31 March 2004 on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells. Off. J. Eur. Union, L102, 48–58. Available online: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32004L0023.
29. European Parliament and Council (2006). Commission Directive 2006/86/EC laying down technical requirements for the coding, processing, preservation, storage and distribution of human tissues and cells. Off. J. Eur. Union, L294, 32–50. Available online: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32006L0086.
30. Principles of bone and tissue banking in Saudi Arabia: 10-year experience report10.1007/s10561-020-09868-7 ↗
31. Establishing a bone bank within a hospital setting in India: Early insights from a tertiary care center in Northern India—A review article10.1007/s10561-024-10146-z ↗
32. The survey of bone allograft transplantation in a Japanese regional bone bank10.1016/j.jos.2023.11.001 ↗
33. American Association of Tissue Banks (2023, December 18). AATB Standards Rebuild Project: Draft 15th Edition Standards For Tissue Banking. Available online: https://www.aatb.org/news/aatb-standards-rebuild-project-draft-15th-edition-standards-tissue-banking.
34. Um, I., Lee, J., Kim, J., Kim, Y., Bakhshalian, N., Jeong, Y., and Ku, J.K. (2021). Allogeneic dentin graft: A review on its osteoinductivity and antigenicity. Materials, 14.10.3390/ma14071713 ↗
35. Waletzko-Hellwig, J., Saemann, M., Schulze, M., Frerich, B., Bader, R., and Dau, M. (2021). Mechanical characterization of human trabecular and formed granulate bone cylinders processed by high hydrostatic pressure. Materials, 14.10.3390/ma14051069 ↗
36. Shao, A., Ling, Y., Chen, L., Wei, L., Fan, C., Lei, D., Xu, L., and Wang, C. (2020). GGTA1/iGb3S double knockout mice: Immunological properties and immunogenicity response to xenogeneic bone matrix. Biomed. Res. Int., 2020.10.1155/2020/9680474 ↗
37. Structural and chemical features of xenograft bone substitutes: A systematic review of in vitro studies
38. Jerbić Radetić, A.T., Zoričić Cvek, S., Tomas, M., Erjavec, I., Oguić, M., Perić Kačarević, Ž., and Cvijanović Peloza, O. (2021). CSBD healing in rats after application of bovine xenogeneic biomaterial enriched with magnesium alloy. Int. J. Mol. Sci., 22.10.3390/ijms22169089 ↗
39. Pröhl, A., Batinic, M., Alkildani, S., Hahn, M., Radenkovic, M., Najman, S., Jung, O., and Barbeck, M. (2021). In vivo analysis of the biocompatibility and bone healing capacity of a novel bone grafting material combined with hyaluronic acid. Int. J. Mol. Sci., 22.10.3390/ijms22094818 ↗
40. The porcine cytomegalovirus (PCMV) will not stop xenotransplantation10.1111/xen.12763 ↗
41. Expert opinion on the identification, risk assessment, and mitigation of microorganisms and parasites relevant to xenotransplantation products from pigs10.1111/xen.12815 ↗
42. U.S. Food and Drug Administration (2024, April 22). Source Animal, Product, Preclinical, And Clinical Issues Concerning the Use of Xenotransplantation Products in Humans: Guidance for Industry, Available online: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/source-animal-product-preclinical-and-clinical-issues-concerning-use-xenotransplantation-products.
43. European Medicines Agency (2019, December 01). Guideline on Xenogeneic Cell-Based Medicinal Products (EMEA/CHMP/CPWP/83508/2009). Available online: https://www.ema.europa.eu/en/xenogeneic-cell-based-medicinal-products-scientific-guideline.
44. Third WHO global consultation on regulatory requirements for xenotransplantation clinical trials10.1111/xen.12513 ↗
45. Clinical performance of alveolar ridge augmentation with xenogeneic bone block grafts versus autogenous bone block grafts: A systematic review10.1016/j.jormas.2020.10.009 ↗
46. Three-dimensional printed hydroxyapatite bone substitutes designed by a novel periodic minimal surface algorithm are highly osteoconductive10.1089/3dp.2022.0134 ↗
47. Progress and prospects of 3D printing human skeletal scaffold
48. Advanced optical methods and materials for fabricating 3D tissue scaffolds
49. Nifant’ev, I., Tavtorkin, A., Komarov, P., Kretov, E., Korchagina, S., Chinova, M., Gavrilov, D., and Ivchenko, P. (2023). Dispersant and protective roles of amphiphilic poly(ethylene phosphate) block copolymers in polyester/bone mineral composites. Int. J. Mol. Sci., 24.10.3390/ijms241311175 ↗
50. Improvement of the mechanical and biological properties of bioactive glasses by the addition of zirconium oxide (ZrO2) as a synthetic bone graft substitute10.1002/jbm.a.37113 ↗
51. Hydroxyapatite nanoparticles: A review of preparation methodologies
52. 3D printing of micro- and nanoscale bone substitutes: A review on technical and translational perspectives10.2147/IJN.S311001 ↗
53. Fabrication of porous tantalum with low elastic modulus and tunable pore size for bone repair10.1021/acsbiomaterials.2c01239 ↗
54. Load-bearing biodegradable polycaprolactone-poly (lactic-co-glycolic acid)- beta tri-calcium phosphate scaffolds for bone tissue regeneration10.1002/pat.4551 ↗
55. Fabrication of biomimetic scaffold through hybrid forming technique10.1002/ces2.10210 ↗
56. Marongiu, G., Verona, M., Cardoni, G., and Capone, A. (2020). Synthetic bone substitutes and mechanical devices for the augmentation of osteoporotic proximal humeral fractures: A systematic review of clinical studies. J. Funct. Biomater., 11.10.3390/jfb11020029 ↗
57. Kang, H., Makkar, P., Padalhin, A., Lee, G., Im, S., and Lee, B. (2020). Comparative study on biodegradation and biocompatibility of multichannel calcium phosphate based bone substitutes. Mater. Sci. Eng. C Mater. Biol. Appl., 110.10.1016/j.msec.2020.110694 ↗
58. Kowalewicz, K., Vorndran, E., Feichtner, F., Waselau, A., Brueckner, M., and Meyer-Lindenberg, A. (2021). In-vivo degradation behavior and osseointegration of 3D powder-printed calcium magnesium phosphate cement scaffolds. Materials, 14.10.3390/ma14040946 ↗
59. Heitzer, M., Zhao, Q., Greven, J., Winnand, P., Zhang, X., Bläsius, F.M., Buhl, E.M., Wolf, M., Neuss, S., and Hildebrand, F. (2023). Evaluation of in vitro biocompatibility of human pulp stem cells with allogeneic, alloplastic, and xenogeneic grafts under the influence of extracellular vesicles. Sci. Rep., 13.10.1038/s41598-023-39410-0 ↗
60. Sallent, I., Capella-Monsonís, H., Procter, P., Bozo, I.Y., Deev, R.V., Zubov, D., Vasyliev, R., Perale, G., Pertici, G., and Baker, J. (2020). The few who made it: Commercially and clinically successful innovative bone grafts. Front. Bioeng. Biotechnol., 8.10.3389/fbioe.2020.00952 ↗
61. Massari, L., Saracco, A., Marchesini, S., Gambuti, E., Delorenzi, A., and Caruso, G. (2024). Safety of a porous hydroxyapatite bone substitute in orthopedics and traumatology: A multi-centric clinical study. J. Funct. Morphol. Kinesiol., 9.10.3390/jfmk9020071 ↗
62. The clinical efficacy of the allogenic demineralized dentin matrix graft for implant placement: A systematic review10.1007/s10006-023-01170-6 ↗
63. Clinical evaluation of the combination of rhPDGF-BB and xenogeneic bone substites for the treatment of severe periodontal intrabony defects: A case series10.11607/prd.6313 ↗
64. Comparison of autogenous tooth materials and other bone grafts10.1007/s13770-021-00333-4 ↗
65. Jung, K.J., Sarkar, S.K., Kim, W.J., Kim, B.R., Park, J.S., and Lee, B.T. (2022). Bone regeneration by multichannel cylindrical granular bone substitutes for regeneration of bone in cases of tumor, fracture, and arthroplasty. Int. J. Environ. Res. Public Health, 19.10.3390/ijerph19148228 ↗
66. Autograft, allograft, and bone graft substitutes: Clinical evidence and indications for use in the setting of orthopaedic trauma surgery10.1097/BOT.0000000000001420 ↗
67. Meesuk, L., Suwanprateeb, J., Thammarakcharoen, F., Tantrawatpan, C., Kheolamai, P., Palang, I., Tantikanlayaporn, D., and Manochantr, S. (2022). Osteogenic differentiation and proliferation potentials of human bone marrow and umbilical cord-derived mesenchymal stem cells on the 3D-printed hydroxyapatite scaffolds. Sci. Rep., 14.10.1038/s41598-022-24160-2 ↗
68. Adamska, P., Pylińska-Dąbrowska, D., Stasiak, M., Sobczak-Zagalska, H., Jusyk, A., Zedler, A., and Studniarek, M. (2024). Tooth autotransplantation, autogenous dentin graft, and growth factor application: A method for preserving the alveolar ridge in cases of severe infra occlusion—A case report and literature review. J. Clin. Med., 13.10.3390/jcm13133902 ↗
69. Printing and Prototyping of Tissues and Scaffolds10.1126/science.1226340 ↗
70. Recent Advances in Bioprinting Techniques: Approaches, Applications and Future Prospects10.1186/s12967-016-1028-0 ↗
71. Extrusion-Based Bioprinting of Multilayered Nanocellulose Constructs for Cell Cultivation Using In Situ Freezing and Preprint CaCl2 Cross-Linking10.1021/acsomega.0c05036 ↗
72. An Overview on Materials and Techniques in 3D Bioprinting Toward Biomedical Application
73. Hao, Y., Cao, B., Deng, L., Li, J., Ran, Z., Wu, J., Pang, B., Tan, J., Luo, D., and Wu, W. (2022). The first 3D-bioprinted personalized active bone to repair bone defects: A case report. Int. J. Bioprint, 9.10.18063/ijb.v9i2.654 ↗
74. Dilemma and Breakthrough of Biodegradable Poly-L-Lactic Acid in Bone Tissue Repair10.1016/j.jmrt.2022.01.164 ↗
75. Challenges in the Use of Zinc and Its Alloys as Biodegradable Metals: Perspective from Biomechanical Compatibility10.1016/j.actbio.2019.07.038 ↗
76. Advancements of 3D Bioprinting in Regenerative Medicine: Exploring Cell Sources for Organ Fabrication10.1016/j.heliyon.2024.e24593 ↗
77. The Regulatory Challenge of 3D Bioprinting10.2217/rme-2022-0194 ↗
78. Bioenergetic-Active Materials Enhance Tissue Regeneration by Modulating Cellular Metabolic State10.1126/sciadv.aay7608 ↗
79. Biomaterial-Based Metabolic Regulation in Regenerative Engineering10.1002/advs.201900819 ↗
80. Hydrogels and Their Role in Bone Tissue Engineering: An Overview10.4103/jpbs.jpbs_237_21 ↗
81. A Review of Hydrogel-Based Composites for Biomedical Applications: Enhancement of Hydrogel Properties by Addition of Rigid Inorganic Fillers10.1007/s10853-015-9382-5 ↗
82. Shen, C., Han, Y., Xiong, H., Wang, Y., Tan, Z., Wei, H., Ding, Q., Ma, L., Ding, C., and Zhao, T. (2025). Multifunctional Hydrogel Scaffolds Based on Polysaccharides and Polymer Matrices Promote Bone Repair: A Review. Int. J. Biol. Macromol., 294.10.1016/j.ijbiomac.2024.139418 ↗
83. Neuro–Bone Tissue Engineering: Emerging Mechanisms, Potential Strategies, and Current Challenges10.1038/s41413-023-00302-8 ↗
84. Zhou, H., Ye, S., Xu, M., Hao, L., Chen, J., Fang, Z., Guo, K., Chen, Y., and Wang, L. (2023). Dynamic Surface Adapts to Multiple Service Stages by Orchestrating Responsive Polymers and Functional Peptides. Biomaterials, 301.10.1016/j.biomaterials.2023.122200 ↗
85. Engineering Immunomodulatory and Osteoinductive Implant Surfaces via Mussel Adhesion-Mediated Ion Coordination and Molecular Clicking10.1038/s41467-021-27816-1 ↗
86. Engineered Nanoparticles for Drug Delivery in Cancer Therapy10.1002/anie.201403036 ↗
87. Zhang, Y., Hu, M., Wang, X., Zhou, Z., and Liu, Y. (2018). Design and Evaluation of Europium Containing Mesoporous Bioactive Glass Nanospheres: Doxorubicin Release Kinetics and Inhibitory Effect on Osteosarcoma MG-63 Cells. Nanomaterials, 8.10.3390/nano8110961 ↗
88. Mesoporous Bioactive Glasses for the Combined Application of Osteosarcoma Treatment and Bone Regeneration10.1016/j.msec.2019.109994 ↗
89. Enhancing Osteosarcoma Killing and CT Imaging Using Ultrahigh Drug Loading and NIR-Responsive Bismuth Sulfide@Mesoporous Silica Nanoparticles10.1002/adhm.201800602 ↗
90. Phosphorus-Containing SBA-15 Materials as Bisphosphonate Carriers for Osteoporosis Treatment10.1016/j.micromeso.2010.06.010 ↗
91. Mesoporous Silica Nanoparticles/Gelatin Porous Composite Scaffolds with Localized and Sustained Release of Vancomycin for Treatment of Infected Bone Defects10.1039/C7TB01246B ↗
92. Fabrication of a Nanoparticle-Containing 3D Porous Bone Scaffold with Proangiogenic and Antibacterial Properties10.1016/j.actbio.2019.01.013 ↗
93. The Possible “Proton Sponge” Effect of Polyethylenimine (PEI) Does Not Include Change in Lysosomal pH10.1038/mt.2012.185 ↗
94. Regeneration of Bone Using Nanoplex Delivery of FGF-2 and BMP-2 Genes in Diaphyseal Long Bone Radial Defects in a Diabetic Rabbit Model10.1016/j.jconrel.2017.01.008 ↗
95. In situ bone tissue engineering using gene delivery nanocomplexes10.1016/j.actbio.2020.03.008 ↗
96. Cell-Free 3D Scaffold with Two-Stage Delivery of miRNA-26a to Regenerate Critical-Sized Bone Defects10.1038/ncomms10376 ↗